Funded Tech Companies
Incyclix Bio
Incyclix Bio, based in Triangle Park, received equity investments through Hatteras Venture Partners, Eli Lilly and Company and Eshelman Ventures.
Company Overview
Company Name
Incyclix Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
600 Park Offices Drive Suite 355 Research
Triangle Park, NC 27709
USA
Triangle Park, NC 27709
USA
Phone
Website
Email Address
Company Background Information
Overview
Developer of small molecule inhibitors of cyclin-dependent kinases (CDKs) intended to provide treatment for patients with advanced and resistant cancers. The company's inhibitors help to achieve the potent and selective inhibition of elusive CDK targets, enabling pharmaceutical companies and medical practitioners with novel drugs to help and improve the treatment of cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/8/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Roberts
Co-Founder
Jay Strum
Company Investors
- Hatteras Venture Partners (Kseniya Simpson)
- Eli Lilly and Company
- Eshelman Ventures
- Cape Fear Ventures
- Boxer Capital
- RA Capital
- Private Investors (Sid Subramony)
Browse more funded tech companies:
Incurrent Solutions | Incysus Therapeutics
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs